Urovant Sciences Ltd. is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for urologic conditions. The company’s mission is to improve the lives of patients suffering from these conditions by providing effective treatment options. Urovant Sciences has a diverse pipeline of products in various stages of development, including treatments for overactive bladder, urinary incontinence, and other urologic disorders. The company is committed to advancing the science of urology and bringing new and innovative therapies to market. With a team of experienced professionals and a strong commitment to patient care, Urovant Sciences is poised to make a significant impact in the field of urology.
